With a robust background in venture capital, the fund manager has executed over 50 investments across the life sciences and biotechnology sectors, primarily within North America and Europe. Emphasizing a data-driven approach, they focus on early to growth-stage companies, fostering innovation through strategic partnerships. The manager has successfully orchestrated several notable exits, demonstrating a keen ability to identify and nurture transformative technologies. Their operator-first style enhances portfolio value, ensuring alignment with market needs and sustainable growth.